HDAC9 and myocardial ischemia: The M13 metabolite 3-hydroxybutyrate (3-HB), a key ketone body, exerts diverse therapeutic effects, including blood pressure reduction, myocardial ischemia protection, and cancer cell apoptosis induction via HDAC inhibition.